GSK Consumer Healthcare Debuts Innovative Self-Care Solutions at China International Import Expo 2019 Following Joint Venture with Pfizer

On November 6, 2019, GSK Consumer Healthcare debuted at the second China International Import Expo (CIIE) with a portfolio of innovative, high-quality self-care products and solutions. This marked its first appearance in the Chinese market under its new business structure, following the completion of its joint venture with Pfizer in the consumer healthcare sector earlier that year. Leveraging the CIIE platform, GSK Consumer Healthcare showcased its rich array of innovative products and services, underpinned by robust scientific expertise and deep consumer insights, thereby providing Chinese consumers with more reliable and effective avenues for self-care and proactive disease prevention.

On August 1 this year, GSK announced the completion of its transaction with Pfizer to integrate their respective consumer healthcare businesses, establishing a globally leading joint venture. The joint venture combines the two companies’ highly complementary and consumer-preferred consumer healthcare brand portfolios, becoming a global leader in the over-the-counter (OTC) product sector, with its market share ranking first or second in all key markets, including China.

During the China International Import Expo (CIIE), GSK Consumer Healthcare showcased a diverse portfolio of innovative, trusted consumer health products to the public. These included vitamins, minerals, and dietary supplements (such as Centrum and Caltrate); skin health products (such as Bactroban); pain management products (such as Fenbid and Voltaren); oral care products (such as Sensodyne and Polident); and respiratory health products (including Contac and Flixonase). Notably, some of the exhibited products were introduced to the Chinese market for the first time via cross-border e-commerce channels. Meanwhile, GSK Consumer Healthcare provided health education to visitors, enhancing their understanding of how to better manage bone health, bodily pain, and tooth sensitivity, while offering hands-on experiences with GSK’s self-care solutions.

For many years, GSK Consumer Healthcare has upheld its mission to “help people do more, feel better, and live longer.” All products and services showcased here reflect GSK Consumer Healthcare’s commitment to the Chinese market and consumers, contributing to more proactive health management, improved disease prevention, and ultimately enhancing the overall health of society, thereby supporting the grand vision of “Healthy China 2030.”

GlaxoSmithKline is a world-leading, science-driven pharmaceutical and healthcare company. We are dedicated to improving the quality of people's lives, helping them do more, feel better, and live longer.

GSK Consumer Healthcare combines scientific expertise with consumer insights to safeguard people’s daily health through innovative brands. As a global leader in pain management, nutritional supplements, respiratory health, skin health, and oral care, GSK Consumer Healthcare offers a portfolio of well-known consumer health products, including trusted brands such as Fenbid, Centrum, Caltrate, Sensodyne, Voltaren, Bactroban, Flixonase, Polident, Contac, Lamisil, Qianlin, Huifeining, IMEDEEN, and Emergen-C, which are highly regarded by Chinese consumers and healthcare professionals alike.